This inventor holds 14 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent, primarily in Gene Cloning Techniques. Top assignees: Icos Corporation, Lucigen Corporation. Active years: 1997-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bothell, WA (US) (1997 - 2004)
- Mount Horeb, WI (US) (2014)
- Verona, WI (US) (2002 - 2015)
- Mt. Horeb, WI (US) (2017)
Company Filing History:
Years Active: 1997-2017
Areas of Expertise:
Title: The Innovations of Ronald Godiska: A Pioneer in Cloning Methods
Introduction
Ronald Godiska, an accomplished inventor based in Verona, Wisconsin, has made significant contributions to the field of biotechnology. With a total of 14 patents to his name, Godiska's work focuses on developing innovative solutions pertaining to linear vectors and cloning methods.
Latest Patents
Among his latest patents is a groundbreaking invention involving linear vectors derived from bacteriophage and host cells suitable for cloning. These linear vectors consist of a left arm featuring a left telomere and a first selectable marker, as well as a right arm comprising a right telomere and a second selectable marker. A cloning region is strategically located between the left and right arms, enhancing the cloning process. Additional optional components of the vector may include transcriptional termination sequences, multiple cloning sites, and reporter stuffer regions, showcasing his attention to detail and innovative spirit.
Career Highlights
Throughout his career, Ronald Godiska has collaborated with esteemed organizations like Icos Corporation and Lucigen Corporation. His experience in these companies has shaped his research and development endeavors within the biotechnology sector.
Collaborations
Godiska has worked alongside notable professionals such as Patrick W Gray and David Mead. Their collaborative efforts have undoubtedly enriched the research environment and fueled innovative advancements in the field.
Conclusion
Ronald Godiska’s work exemplifies the importance of innovation in the biotechnology industry. His patents and collaborative efforts reflect a commitment to advancing methods in cloning and vector development. As he continues to push the boundaries of research, his contributions will undoubtedly leave a lasting impact on the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile